Partner Notification and Treatment — MCQs
What is the minimum percentage of partner notification required for effective STI control according to NACO guidelines?
A 24-year-old woman presents with abnormal vaginal discharge. Wet mount shows motile trichomonads. Her male partner is asymptomatic. Which of the following is the most appropriate management for her partner?
A patient with gonorrhea infection shows persistence of symptoms despite appropriate treatment with Ceftriaxone. Which of the following best explains this treatment failure?
A 23-year-old woman is diagnosed with chlamydia. Her partner refuses testing. What contact tracing approach is most appropriate?
Which of the following statements about screening for chlamydia and gonorrhea is MOST accurate?
Treatment of partner is required in all infection except:
What is the most appropriate intervention for a client expressing concerns about erectile dysfunction and its potential impact on his marriage?
A 22-year-old woman presents for STI screening. She reports multiple sexual partners and inconsistent condom use. What screening tests would be most appropriate?
Which statement about the CDC recommendation for gonorrhea treatment is MOST accurate?
In the context of AIDS control programs, which sexually transmitted infection is specifically treated with the blue-colored pack?
Partner Notification and Treatment Indian Medical PG Practice Questions and MCQs
Question 1: What is the minimum percentage of partner notification required for effective STI control according to NACO guidelines?
- A. 95%
- B. 80% (Correct Answer)
- C. 65%
- D. 50%
Explanation: ***80%*** - NACO guidelines emphasize that a **minimum of 80% partner notification** is required for effective control of sexually transmitted infections (STIs). - Achieving this threshold helps in **breaking the chain of transmission** by identifying and treating exposed individuals. *95%* - While 95% is an aspirational target for some public health interventions, it is not the **minimum required percentage** specifically stated by NACO for effective STI partner notification. - This level of notification would provide even greater control but is often difficult to achieve in practice. *65%* - A 65% partner notification rate is considered **insufficient** by NACO guidelines to effectively control STI transmission within a population. - This rate would likely lead to a significant number of **untreated partners**, allowing the infection to continue spreading. *50%* - A 50% partner notification rate is **far below** the recommended minimum by NACO, making it largely ineffective for STI control. - Such a low rate would result in a substantial number of **missed cases** and ongoing transmission.
Question 2: A 24-year-old woman presents with abnormal vaginal discharge. Wet mount shows motile trichomonads. Her male partner is asymptomatic. Which of the following is the most appropriate management for her partner?
- A. Treat regardless of symptoms (Correct Answer)
- B. No treatment unless symptoms develop
- C. Test before treating
- D. Monitor without intervention
Explanation: ***Treat regardless of symptoms*** - **Trichomoniasis** is a sexually transmitted infection, and partners of infected individuals should be treated even if they are asymptomatic to prevent **reinfection** and further transmission. - **Male partners** often carry the infection asymptomatically, acting as a reservoir for transmission. *No treatment unless symptoms develop* - This approach would lead to **persistent infection** in the male partner and an increased risk of **reinfection** for the female patient. - Asymptomatic carriers can still transmit the infection, undermining the treatment of the symptomatic partner. *Test before treating* - While testing is possible, current guidelines recommend **presumptive treatment** for male partners of women diagnosed with trichomoniasis to ensure effective eradication and prevent recurrence. - The **sensitivity** of diagnostic tests for trichomoniasis in men can be lower than in women, potentially leading to false negatives. *Monitor without intervention* - Monitoring without intervention is inadequate as it allows the male partner to remain an **infectious source** and risks **recurrent infection** for the female patient. - The goal is to break the chain of transmission and fully cure both partners.
Question 3: A patient with gonorrhea infection shows persistence of symptoms despite appropriate treatment with Ceftriaxone. Which of the following best explains this treatment failure?
- A. Reinfection from untreated partner (Correct Answer)
- B. Host immune deficiency
- C. Initial misdiagnosis
- D. Development of new resistance during therapy
Explanation: ***Reinfection from untreated partner*** - The most common reason for persistent gonorrhea symptoms despite appropriate treatment is **re-exposure** to the infection from an **untreated sexual partner** [1]. - This highlights the importance of **partner notification and treatment** in managing sexually transmitted infections [1]. *Host immune deficiency* - While host immune status can influence the severity or recurrence of infections, a primary **immune deficiency** is a less common explanation for treatment failure of uncomplicated gonorrhea, especially with an effective antibiotic like ceftriaxone. - Gonorrhea is typically managed effectively with standard antibiotic regimens, even in individuals with common viral infections like HIV, unless there are severe, unmanaged coinfections or systemic immunosuppression. *Initial misdiagnosis* - An initial misdiagnosis could lead to persistent symptoms if the patient never had gonorrhea or had another co-infection that was not treated. However, the question states "gonorrhea infection" and "appropriate treatment with Ceftriaxone," implying the diagnosis was correct and the treatment regimen was standard. - This option does not explain why the **specific treatment for gonorrhea** failed, but rather suggests a fundamental error in the diagnostic process. *Development of new resistance during therapy* - Although **antibiotic resistance** in *Neisseria gonorrhoeae* is a growing concern, the development of *new* resistance mutations *during* a typical short course of effective ceftriaxone treatment for an initial infection is rare [1]. - More commonly, resistance profiles are established before treatment, or an existing resistant strain was acquired, rather than a new mutation arising and causing failure within the short therapeutic window.
Question 4: A 23-year-old woman is diagnosed with chlamydia. Her partner refuses testing. What contact tracing approach is most appropriate?
- A. Expedited partner therapy (Correct Answer)
- B. Patient referral only
- C. Contract referral
- D. Provider referral only
Explanation: ***Expedited partner therapy (EPT)*** - This approach allows clinicians to provide medication or a prescription for a partner without a prior medical examination, facilitating treatment when a partner is unwilling or unable to seek care. - It is particularly useful for **chlamydia** and **gonorrhea** to reduce reinfection rates and further transmission. - **Recommended by CDC and WHO** for STI partner management when partners are unlikely to present for care. - *Note: EPT implementation varies by country; in India, partner notification with clinical evaluation is standard practice, but EPT represents the most direct approach when partners refuse testing.* *Patient referral only* - Relying solely on the patient to inform and encourage their partner to seek testing and treatment can be effective but carries a risk of the partner not following through, leading to continued transmission. - This method might be less successful if the partner is uncooperative or unwilling to get tested, as is implied in this scenario. - **Most commonly used approach** in resource-limited settings but has lower success rates. *Contract referral* - Involves the patient agreeing to notify their partner, with the understanding that if the partner does not present for treatment within a specified timeframe, health officials will then intervene. - While it offers a backup, it still relies on initial patient action and may not be immediate enough when a partner is actively refusing testing. - Provides a **safety net** but involves delays in partner treatment. *Provider referral only* - This method involves a healthcare provider directly contacting the partner to inform them of exposure and recommend testing and treatment, respecting patient confidentiality. - This option is generally preferred when there are concerns about the patient's safety or if the patient is unable or unwilling to notify their partner. - More resource-intensive and requires **trained health workers** for partner notification, but ensures partners are reached even if the index patient cannot or will not inform them.
Question 5: Which of the following statements about screening for chlamydia and gonorrhea is MOST accurate?
- A. Screening is not cost-effective and should be avoided in low-risk populations
- B. Screening is recommended for sexually active women under 25, men who have sex with men, and pregnant women (Correct Answer)
- C. Screening is only recommended for patients with symptoms
- D. Annual screening is recommended for all sexually active adults regardless of age or risk factors
Explanation: ***Screening is recommended for sexually active women under 25, men who have sex with men, and pregnant women*** - This statement aligns with current **CDC guidelines** which prioritize screening in populations with a higher prevalence or increased risk of complications from chlamydia and gonorrhea. - Early detection and treatment in these groups can prevent serious long-term health consequences like **pelvic inflammatory disease (PID)**, **infertility**, and **adverse pregnancy outcomes**. *Screening is not cost-effective and should be avoided in low-risk populations* - While screening in genuinely low-risk populations might be less cost-effective, chlamydia and gonorrhea often have **asymptomatic presentations**, making targeted screening essential for disease control. - The long-term costs associated with untreated infections (e.g., infertility treatment, chronic pain) often outweigh the costs of screening, even in lower-prevalence settings, when focused on at-risk groups. *Screening is only recommended for patients with symptoms* - This statement is incorrect because a significant proportion of chlamydia and gonorrhea infections are **asymptomatic**, meaning individuals can be infected and transmit the infection without showing any symptoms. - Relying only on symptoms would lead to widespread **undetected infections** and continued transmission within communities. *Annual screening is recommended for all sexually active adults regardless of age or risk factors* - While broad screening might seem comprehensive, current guidelines emphasize **targeted screening** based on age, sexual history, and risk factors to optimize resource allocation and maximize public health impact. - Overly broad screening in genuinely low-risk older populations may not be the most **cost-effective strategy**.
Question 6: Treatment of partner is required in all infection except:
- A. Trichomonas
- B. Herpes
- C. Gardnerella (Correct Answer)
- D. Candida
Explanation: ***Gardnerella*** - **Gardnerella vaginalis** is a common inhabitant of the vaginal flora and its overgrowth causes **bacterial vaginosis**, which is not typically considered a sexually transmitted infection (STI) in the same way others are. - While it can be transmitted sexually, treating the male partner has not been shown to prevent recurrence in the female; therefore, routine **partner treatment is generally not recommended**. *Trichomonas* - **Trichomoniasis** is a sexually transmitted infection caused by the parasite **Trichomonas vaginalis**. [1] - **Partner treatment is essential** to prevent reinfection and interrupt the cycle of transmission, as asymptomatic infection is common. [1] *Herpes* - **Genital herpes** is caused by the **Herpes Simplex Virus (HSV)** and is highly transmissible sexually. [2] - While treatment often focuses on managing symptoms in the infected individual, open communication and potential treatment or counseling for partners are crucial to prevent transmission and manage outbreaks. *Candida* - **Candidiasis** (yeast infection) is typically caused by an overgrowth of **Candida albicans**, a fungus naturally present in the body. - While it is not strictly an STI, sexual activity can sometimes trigger or exacerbate symptoms, and in recurrent cases, treating a male partner might be considered, but **it's not routinely required** as it is for true STIs like trichomonas or chlamydia. [2]
Question 7: What is the most appropriate intervention for a client expressing concerns about erectile dysfunction and its potential impact on his marriage?
- A. Suggest referral to a sex counselor or other appropriate professional. (Correct Answer)
- B. Encourage the client to discuss his feelings about erectile dysfunction.
- C. Provide information on sexual health resources.
- D. Encourage the client to bring his partner to counseling sessions.
Explanation: ***Suggest referral to a sex counselor or other appropriate professional.*** - Referral to an **appropriate professional** (which may include physicians for medical evaluation and sex counselors for psychological aspects) is the most comprehensive approach for **erectile dysfunction (ED)**. - ED often has multiple etiologies—**organic** (cardiovascular disease, diabetes, medications, hormonal imbalances) and **psychological** (performance anxiety, relationship issues, depression)—requiring interdisciplinary assessment. - A **sex counselor** or therapist can address the psychological and relational dimensions, while medical professionals can evaluate and treat underlying physical causes. - This intervention provides **specialized, expert guidance** that addresses both the physiological and emotional aspects affecting the marriage. *Encourage the client to discuss his feelings about impotence.* - While exploring feelings is an important therapeutic intervention, it is **insufficient as a sole intervention** when the underlying cause of ED may be medical. - This approach does not address potential **organic causes** or provide the specialized strategies needed for comprehensive ED management. - Without professional evaluation, the client may continue to experience distress without appropriate medical or psychological treatment. *Provide information on sexual health resources.* - Offering resources is helpful as an **adjunct intervention**, but it's a **passive approach** that lacks personalized assessment and treatment. - The client may feel **overwhelmed** without professional guidance on which resources are relevant to his specific situation. - This does not ensure proper evaluation to differentiate between organic and psychogenic causes of ED. *Encourage the client to bring his partner to counseling sessions.* - While **couples therapy** can be beneficial, particularly for relationship factors contributing to ED, it may not be the **initial priority**. - The client may need **individual assessment** first to explore personal concerns, rule out medical causes, and reduce feelings of vulnerability before involving the partner. - Premature couple involvement might increase **performance anxiety** or resistance if the client is not ready to discuss this sensitive issue with his partner present.
Question 8: A 22-year-old woman presents for STI screening. She reports multiple sexual partners and inconsistent condom use. What screening tests would be most appropriate?
- A. HPV DNA testing only
- B. Complete blood count and urinalysis
- C. HIV and syphilis testing only
- D. HIV, syphilis, gonorrhea, and chlamydia testing (Correct Answer)
Explanation: ***HIV, syphilis, gonorrhea, and chlamydia testing*** - This comprehensive panel screens for the most common bacterial and viral STIs in sexually active individuals with **multiple partners** and **inconsistent condom use**, as recommended by **NACO and WHO guidelines**. - **Gonorrhea and chlamydia** often present asymptomatically but can lead to serious reproductive health complications including pelvic inflammatory disease (PID) and infertility if untreated. - In high-risk populations, comprehensive screening is essential for early detection and prevention of transmission. *HPV DNA testing only* - **HPV DNA testing** is primarily for cervical cancer screening in women over 30 years or as a co-test with cytology; it doesn't cover other STIs. - While HPV is common, testing for other prevalent STIs like chlamydia, gonorrhea, syphilis, and HIV is crucial given her risk factors. *Complete blood count and urinalysis* - A **complete blood count (CBC)** assesses overall health and detects conditions like anemia or infection but is not a specific STI screening test. - **Urinalysis** checks for urinary tract infections or kidney issues and does not directly screen for STIs. - These are general screening tests and miss the targeted STI screening needed. *HIV and syphilis testing only* - Although **HIV and syphilis testing** are essential components of STI screening, this option misses other common and treatable bacterial STIs like gonorrhea and chlamydia. - Given the patient's risk factors (multiple partners, inconsistent condom use), a more comprehensive screening panel is warranted to prevent long-term reproductive complications.
Question 9: Which statement about the CDC recommendation for gonorrhea treatment is MOST accurate?
- A. Spectinomycin is the recommended alternative for cephalosporin allergy
- B. Fluoroquinolones remain first-line for uncomplicated infection
- C. Monotherapy with high-dose ceftriaxone is now preferred (Correct Answer)
- D. Dual therapy with ceftriaxone plus azithromycin is recommended
Explanation: ***Monotherapy with high-dose ceftriaxone is now preferred*** - The CDC recently updated its recommendations, endorsing **monotherapy with a single, higher dose of ceftriaxone (500 mg IM)** for uncomplicated gonococcal infections in adults [1]. - This change reflects concerns about rising **antimicrobial resistance** and simplifies treatment strategies [1]. *Spectinomycin is the recommended alternative for cephalosporin allergy* - While spectinomycin *was* an alternative in some regions, it is **not available in the United States**, rendering it impractical for current CDC recommendations. - For patients with **cephalosporin allergy**, alternative regimens such as gentamicin plus azithromycin or azithromycin monotherapy (if susceptibility can be confirmed) are considered. *Fluoroquinolones remain first-line for uncomplicated infection* - **Fluoroquinolones are no longer recommended** for gonorrhea treatment due to widespread resistance; this recommendation was withdrawn in 2007. - The CDC specifically advises against the use of **ciprofloxacin, ofloxacin, or levofloxacin** for gonorrhea [1]. *Dual therapy with ceftriaxone plus azithromycin is recommended* - **Dual therapy with ceftriaxone and azithromycin** was recommended in the past to prevent the development of resistance. - However, due to concerns about **azithromycin resistance** and data showing the efficacy of higher-dose ceftriaxone monotherapy, the CDC has revised its guidelines [1].
Question 10: In the context of AIDS control programs, which sexually transmitted infection is specifically treated with the blue-colored pack?
- A. Urethral discharge
- B. Scrotal swelling
- C. Genital ulcers (Correct Answer)
- D. Ano-rectal discharge
Explanation: ***Genital ulcers*** - The "blue-colored pack" in AIDS control programs is specifically designed for the syndromic management of **genital ulcer disease (GUD)**. - Treating GUD is crucial for AIDS control strategies because genital ulcers facilitate **HIV transmission** by breaking the mucosal barrier. *Urethral discharge* - Urethral discharge is typically managed with the **green-colored pack**, which targets pathogens commonly causing urethritis. - This symptom primarily indicates **gonorrhea** or **chlamydia**, which are distinct from genital ulcers in their syndromic management. *Scrotal swelling* - Scrotal swelling is managed with the **white-colored pack**, which focuses on conditions like **epididymitis** or **orchitis**. - This syndromic approach addresses infections causing inflammation of the testes and epididymis, which are different from GUD. *Ano-rectal discharge* - Ano-rectal discharge is generally addressed with the **green-colored pack**, similar to urethral discharge, targeting pathogens like **gonorrhea** and **chlamydia**. - While anogenital infections can manifest in various ways, discharge from the anorectal area is managed differently from genital ulcers.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free